UK’s Semble bags €13.8M funding to reduce the administrative burden on medical professionals: Here’s how

London-based Semble, a healthcare software company, announced on Tuesday that it has secured $15M (approximately €13.8M) in a Series B funding round led by Mercia Ventures, with participation from Octopus Ventures, Smedvig Ventures, and Triple Point. 

The company will use the funds to consolidate its position in the UK market and expand its presence in France, where it launched earlier this month.

This latest Series B round brings the total raised to $27M (approximately €24.9M). 

Christoph Lippuner, CEO, says, “Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient. With this latest funding, we are looking to bring Semble to professionals across the UK and France, empowering them to spend more time on patient care. We will continue to invest heavily in workflow automation and integrations, positioning Semble at the forefront of AI-driven solutions, and ultimately creating a more connected healthcare ecosystem.” 

Semble: Providing integrated clinical system

Christoph Lippuner and Mikael Landau founded Semble in 2018 after experiencing challenges in the healthcare sector. They founded the company to reduce the administrative burden on medical professionals. 

Semble is an integrated clinical system designed for healthcare businesses of all sizes.

The system enables healthcare businesses to automate tasks while providing secure patient data exchange by integrating with third-party systems, such as hospitals, laboratories, and pharmacies.

Currently, the platform is used by over 10,000 healthcare professionals across the UK and France, supporting more than 70 specialties.

To amplify the impact on healthcare professionals, the UK company enhances operational efficiencies, speeds up medical and admin tasks, improves interoperability, and unlocks the power of data for the healthcare industry. 

The investors

Mercia Ventures is a proactive venture capital investor that makes equity investments of up to £10M across all sectors, with specialisms in Software, Consumer, Healthcare, and Deep Tech. 

The Group has 11 offices in the UK and Mercia Ventures’ national footprint and 48-strong investment team draws on their experiences as founders, PhD scientists, software engineers, corporate financiers, and management consultants to help its partner companies successfully achieve their ambitions.

Alex Gwyther of Mercia Ventures adds, “The healthcare market is experiencing significant growth, but the industry’s continued reliance on legacy systems poses a real threat to its future. Semble is pioneering an all-in-one clinical system that enables healthcare businesses to automate many aspects of their practice. This investment will help Semble accelerate product development and expand its presence in the UK and France, empowering healthcare organisations to deliver on their digital transformation and transform their patients’ experience. With the founders’ first-hand understanding of the challenges in the healthcare sector and its rapid growth to date, we are in no doubt that Semble is well poised to seize this massive market opportunity.”